Atlas Trials

Palmoplantar Pustulosis

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Palmoplantar Pustulosis

RecordFirmDate
Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) (NCT05174065)Amgen2022-03-08
A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) (NCT05194839)Aristea Therapeutics, Inc.2022-01-05
A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan (NCT04459507)Janssen Pharmaceutical K.K.2021-03-22
A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab (NCT04493424)Boehringer Ingelheim2020-09-04
A Study of KHK4827 in Subjects With Palmoplantar Pustulosis (NCT04061252)Kyowa Kirin Co., Ltd.2019-08-10
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis (NCT03633396)Vanda Pharmaceuticals2019-05-20
A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) (NCT03988335)Aristea Therapeutics, Inc.2019-02-13
An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis (NCT02641730)Janssen Pharmaceutical K.K.2015-12-15
Anakinra for Inflammatory Pustular Skin Diseases (NCT01794117)National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2013-07-22
Immune Signature of Palmoplantar Pustulosis (NCT01780857)Baylor Research Institute2013-06-01
Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence (NCT04566471)Peking University Third Hospital2012-01-01

Track Palmoplantar Pustulosis automatically

Every clearance here is in the API, with alerts when new ones post.